Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
15.83
-0.96 (-5.72%)
At close: Nov 15, 2024, 4:00 PM
16.00
+0.17 (1.07%)
After-hours: Nov 15, 2024, 7:59 PM EST
Syndax Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -297.06 | -209.36 | -149.34 | 24.93 | -73.16 | -56.05 | |
| Depreciation & Amortization | 0.01 | 0.01 | 0.03 | 0.04 | 0.09 | 0.09 | |
| Loss (Gain) From Sale of Investments | -13.99 | -14.8 | -3.38 | 0.64 | -0.13 | -0.78 | |
| Stock-Based Compensation | 39.06 | 30.95 | 16.02 | 13.32 | 9.06 | 6.01 | |
| Other Operating Activities | 1.02 | 0.74 | 1.34 | -0.2 | 0.82 | 0.36 | |
| Change in Accounts Payable | -1.15 | 5.61 | -1.32 | 2.16 | -2.67 | 4.74 | |
| Change in Unearned Revenue | - | - | - | -13.13 | -1.52 | -1.52 | |
| Change in Other Net Operating Assets | 16.75 | 26.25 | 2.98 | 1.38 | -3.75 | -3.46 | |
| Operating Cash Flow | -258.86 | -160.6 | -133.68 | 29.13 | -71.26 | -50.61 | |
| Capital Expenditures | - | - | - | -0.13 | - | - | |
| Sale of Property, Plant & Equipment | - | - | 0.23 | - | - | - | |
| Investment in Securities | 32.91 | 117.61 | -186.41 | -40.74 | -142.53 | 12.78 | |
| Investing Cash Flow | 32.91 | 117.61 | -186.19 | -40.87 | -142.53 | 12.78 | |
| Long-Term Debt Issued | - | - | - | - | 19.73 | - | |
| Long-Term Debt Repaid | - | - | -21 | - | - | - | |
| Net Debt Issued (Repaid) | - | - | -21 | - | 19.73 | - | |
| Issuance of Common Stock | 264.43 | 264.13 | 193.25 | 117.89 | 284.69 | 28.57 | |
| Other Financing Activities | - | - | - | 0.58 | 0 | - | |
| Financing Cash Flow | 264.43 | 264.13 | 172.25 | 118.46 | 304.42 | 28.57 | |
| Net Cash Flow | 38.47 | 221.14 | -147.61 | 106.72 | 90.63 | -9.26 | |
| Free Cash Flow | -258.86 | -160.6 | -133.68 | 29 | -71.26 | -50.61 | |
| Free Cash Flow Margin | -1617.90% | - | - | 20.76% | -4697.43% | -3336.32% | |
| Free Cash Flow Per Share | -3.15 | -2.28 | -2.20 | 0.54 | -1.73 | -1.66 | |
| Cash Interest Paid | - | - | 2.06 | 2 | 1.63 | - | |
| Levered Free Cash Flow | -142.71 | -82.37 | -76.27 | 32.03 | -38.44 | -27.57 | |
| Unlevered Free Cash Flow | -142.59 | -82.24 | -74.31 | 33.22 | -36.97 | -27.57 | |
| Change in Net Working Capital | -19.1 | -30.52 | -4.48 | -3.6 | 1.48 | -2.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.